EGFR and cancer: Constitutive activation of the PI3K/AKT signaling has been believed to be a significant determinant for cell growth and survival in a variety of cancers, which can be over-activated by tyrosine kinases, especially insulin-like growth factor receptor (IGFR) and epidermal growth factor receptor (EGFR) 16, 20.